Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction

NCT02579772 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: N-acetylcysteine
DRUG: Placebo

Sponsor

Queen's University